A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Craig Lammert, MD
Indiana University
Principal Investigator - Ethan Weinberg, MD
University of Pennsylvania
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Arizona
Phoenix, Arizona, United States
- Keck School of Medicine of Usc
Los Angeles, California, United States
- University of California, Los Angeles
Los Angeles, California, United States
- Stanford Medicine
Redwood City, California, United States
- California Pacific Medical Center
San Francisco, California, United States
- University of California, San Francisco
San Francisco, California, United States
- University of Colorado
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- University of Miami
Miami, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Northwell Health Center for Liver Disease and Transplantation
Manhasset, New York, United States
- New York University Langone Health/grossman School of Medicine
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 May 2023
- Primary completion
- 30 Apr 2025
- Completion
- 30 Apr 2025
- Last update posted
- 13 Jan 2026
- Registered enrollment
- 24
- Registry id
- NCT05569759
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.